微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.83% | 431.94% | 907.89% | 75/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.38% | 231.03% | -69.84% | 102/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.26% | 320% | 373.91% | 73/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -0.46% | -109.83% | -163.89% | 105/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.72% | -87.07% | 348.28% | 107/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -0.29% | -106.64% | -196.67% | 117/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.3% | -88.89% | -93.59% | 109/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.68% | -57.49% | -15.98% | 65/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.57% | -35.9% | 27.46% | 62/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.37% | -34.09% | 61.85% | 50/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.7% | -48.37% | -75.48% | 44/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.01% | -34.85% | 26.7% | 39/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.69% | 2% | 31.07% | 38/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.63% | -29.99% | 26.77% | 30/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.23% | 2% | -69.05% | 12/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.9% | -24.96% | 78.46% | 15/159 | 0.75% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 9.47% | -36.14% | -57.95% | 17/159 | 2.94% | 小方制药 | 71.99% | 行业排名> |
| 2020-12-31 | 22.52% | -19.94% | 51.85% | 15/159 | 3.58% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-06-30 | 14.83% | 21.46% | -47.28% | 8/159 | 4.19% | 汇宇制药 | 28.14% | 行业排名> |
| 2019-12-31 | 28.13% | 20.68% | 20.68% | 7/159 | 2.53% | 哈三联 | 27.17% | 行业排名> |
| 2018-12-31 | 23.31% | 7.82% | 90.91% | 7/159 | 6.99% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-06-30 | 12.21% | 0.66% | -43.52% | 7/159 | 4.6% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 21.62% | 2% | 78.24% | 10/159 | 9.61% | 汇宇制药 | 31.9% | 行业排名> |
| 2017-06-30 | 12.13% | 2% | 2% | 7/159 | 5.58% | 誉衡药业 | 35.56% | 行业排名> |